Skip to main content
. 2018 Nov 8;23(1):205–215. doi: 10.1111/jcmm.13909

Figure 5.

Figure 5

miR‐520b exerts oncogenic effect on NSCLC cells through GLI2/3. (A, B) MTT assays of A549 cells (A) and H1299 cells (B) transfected with indicated constructs. (C) MTT assays of A549 cells (left) and H1299 cells (right) under indicated treatment. (D) Wound healing assays of A549 cells under indicated treatment. Quantification of wound closure at indicated time‐points was shown on the right. All values are mean ± SD (n = 3, ***P < 0.001 and NS, no significance)